Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2019-05-06 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of medical device registration certificates issued by a regulatory authority (Hunan Food and Drug Administration). It details the product names, registration numbers, validity periods, classifications, and intended uses. The document is short (1364 characters) and serves as an official notification to investors about regulatory approvals obtained by the company. There is no financial data, no detailed report, no management discussion, or earnings information. It is not a report publication announcement since it contains substantive content about the certificates obtained. The document fits best into a general regulatory announcement category, as it informs about compliance and regulatory status but does not fit into other specific categories like Annual Report, Earnings Release, or Management Reports. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2019-05-06 Chinese
2018年年度审计报告（更新后）
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告" which translates to "Audit Report" for the fiscal year 2018 of 三诺生物传感股份有限公司. It contains detailed audit opinions, basis for audit opinions, key audit matters, responsibilities of management and auditors, and extensive financial statements including consolidated and parent company balance sheets, profit and loss statements, and notes. The presence of detailed audit procedures, auditor's opinion, and comprehensive financial data confirms this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters) and contains actual financial data and audit details, not just an announcement or certification. Therefore, the correct classification is Audit Report / Information (AR).
2019-04-30 Chinese
2018年年度报告（更新后）
Annual Report Classification · 100% confidence The document is titled as the "2018 年年度报告全文" which translates to "2018 Annual Report Full Text" for 三诺生物传感股份有限公司 (Sinocare Inc.). It contains detailed sections typical of an annual report, including company overview, financial data, risk factors, business summary, asset changes, and governance information. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. It includes audited financial data, management discussion, and detailed disclosures consistent with an official yearly report. Therefore, this document fits the definition of an Annual Report (10-K).
2019-04-30 Chinese
关于《2018年年度报告》的更正公告
Regulatory Filings Classification · 95% confidence The document is a correction announcement regarding the company's 2018 Annual Report and 2018 Annual Audit Report. It specifies a data correction in the consolidated profit statement, clarifying a numerical error in the investment income from associates and joint ventures. The document states that the corrected 2018 Annual Report and Audit Report are disclosed simultaneously on the official information website. The document is about correcting and clarifying previously published annual report data rather than presenting the full annual report itself. The length is about 5,211 characters, which is relatively short and focused on correction. This fits the pattern of a Regulatory Filing (RNS) as it is a regulatory announcement correcting previously filed financial data, not the full annual report or audit report itself.
2019-04-30 Chinese
2018年年度股东大会的法律意见书
Regulatory Filings
2019-04-29 Chinese
2018年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the 2018 Annual General Meeting (AGM) of 三诺生物传感股份有限公司. It details the voting results on various proposals including the 2018 annual board report, supervisory board report, annual report, financial report, profit distribution plan, and other related matters. The document includes specifics on voting methods, attendance, and legal opinions confirming the validity of the meeting and resolutions. There is no presentation material or detailed financial data, but rather the official announcement of the voting results from the AGM. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 4783 characters, which is sufficient for a detailed voting result announcement but not a full report or presentation. Therefore, the correct classification is DVA with high confidence.
2019-04-29 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.